Despite losing four tosses on the bounce in their 2025 Champions Trophy campaign, the Indian team has been unstoppable in their quest to win the trophy for the first time since 2013. With the ...

Investing.com -- The US Food and Drug Administration has accepted GlaxoSmithKline (NYSE:GSK)’s biologics license application for depemokimab, a monoclonal antibody targeting interleukin-5 (IL-5), for ...

LONDON - GSK plc, the global healthcare company, has released its Annual Report for the fiscal year ending December 31, 2024. The report was published on the company's website today and is also set to ...

The Coca-Cola Company (NYSE:KO), a global beverage giant with a market capitalization of $305 billion, continues to navigate a complex market landscape characterized by strong brand performance, ...

However, the company faces intense competition in this space, with established players like Pfizer and GlaxoSmithKline holding strong market positions. Moderna’s ability to capture market share with ...

The stock of GlaxoSmithKline Pharmaceuticals (GSK Pharma) hit a three-month high of ₹2,640 a share as it surged 5 per cent on Monday before closing at ₹2,638. During the past seven trading days, the ...

However, the company faces intense competition in this space, with established players like Pfizer and GlaxoSmithKline holding strong market positions. Moderna's ability to capture market share ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase "defensive" as the ...